F-Prime Capital — 2024 Investments
25 investments dated 2024 · listed companies and verified rows first · show all
Denali Therapeutics develops therapeutics for neurodegenerative diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
Marc Tessier-Lavigne(Founder)inAlexander O. Schuth(Executive Officer)inRyan J. Watts(President, Chief Executive Officer and Director)inCarole Ho(Executive Officer)inSteve E. Krognes(Director)inAlexander Schuth(Founder)
Co-investorsARCH Venture PartnersEcoR1 CapitalForesite CapitalGV (Google Ventures)Flagship PioneeringFlagship Ventures
Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women.
BiotechFemTechHealthtechConcord, US
Mike Young(Founder)inT Scott Johnson(Founder)inPaul Antinori(Executive Officer)Allison August(Executive Officer)inThomas Scott Johnson(Executive Officer, Director)
BoardBrendan Bulik-Sullivan(Director)in
Board seatMuz MansuriKetan Patel· per SEC Form D
Co-investorsAtlas VentureGV (Google Ventures)Broadview VenturesLilly Asia VenturesNew Enterprise Associates (NEA)
TripSuite is a software platform for travel agencies that combines CRM, commission tracking, accounting, itinerary management, analytics, and workflow automation in one system.
SaaSTravel & HospitalityBrooklyn, US
Jacey Jones(Executive Officer, Director, Promoter)inChristopher John Graves(Executive Officer, Director, Promoter)
Board seatGaurav Tuli· per SEC Form D
Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.
HealthtechMedical DevicesSan Francisco, US
Shreya Mehta(CTO)inNick Damiano(CEO)inJohn Beck(Executive Officer)in
BoardBryan Kim(Director)Blayne Roeder(Director)
Board seatRobert Weisskoff· per SEC Form D
Co-investorsAstiaCloudStone CapitalDorm RoomShangBay Capital LLCY CombinatorAgrolimen Ventures+15 more
Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.
Medical Devices
Co-investorsIntuitive VenturesLightstone VenturesNew Enterprise Associates (NEA)Oxford Science Enterprises
AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.
BiotechLongevityMedical Devices
Andrew Schiermeier(Chief Executive Officer)in
Co-investorsNovo HoldingsBlackstone Life SciencesEight Roads VenturesNYBC Ventures
Burro builds autonomous robots for agricultural and outdoor operations that mow, tow, carry, and spray to automate manual labor tasks.
AgTechAI & Machine LearningRobotics
Terry Scott(Founder)inCharlie Andersen(Founder)Vibhor Sood(Founder)
Co-investorsAsimov VenturesCatalyst InvestorsCIBUS ENTERPRISE FUND II LPEverywhere VenturesFf Venture CapitalNextFab Ventures+6 more
Chaos Labs builds AI-driven intelligence and risk-management infrastructure that converts fragmented data into institutional-grade insights, offering risk simulations, parameter tuning, and oracle technology for crypto protocols and financial institutions.
AI & Machine LearningCrypto & Web3Data & Infrastructure
Omer Goldberg(Founder)in
Co-investorsBalaji SrinivasanBlueYard CapitalCoinbase VenturesGalaxy VenturesHaun VenturesLightspeed Venture Partners+14 more
Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders.
BiotechDigital HealthMedical DevicesSan Diego, US
Stephen(Co-founder, EVP Research & Development and Chief Development Officer)Paul Cayer(Chief Financial Officer)inVikram(President and Chief Executive Officer)Kimberly(Chief Scientific Officer)Quentin(Chief Technical Officer)
Co-investorsForesite CapitalLongwood FundNorwest Venture PartnersPivotal Life SciencesRiverVest Venture PartnersYsios Capital+4 more
Expressable provides speech therapy services using research-based techniques with a focus on family engagement and accessibility.
Digital HealthHealthtechSaaSAustin, US
Nicholas Barbara(Executive Officer, Director)inLeanne Sherred(President and Chief Clinical Officer)inBenjamin Pincus(Executive Officer)inSpencer Magloff(Executive Officer)inRyan Hinojosa(Executive Officer)Brett Cook(Director)
Co-investorsDigitalis VenturesLerer HippeauNextView VenturesHarbourVest Partners (Canada)
Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.
HealthtechMiami Lakes, US
Carlos D. Bustamante(Executive Officer, Director)inArthur Polk(Executive Officer)Alexander Ioannidis(Director)
BoardWale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)
Co-investorsCEI VenturesCitta CapitalFounder CollectiveFunction VenturesHelios Digital VenturesLifeX Ventures+4 more
Laurus Bio, a subsidiary of Laurus Labs, is a biomanufacturing company using precision fermentation and recombinant DNA technology to produce animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements.
BiotechDeep TechFoodTechNew MaterialsBengaluru, IN
Subramani Ramachandrappa(Founder and Non-Executive Director)inRajesh Krishnamurthy(Executive Director & CEO)inKrishna Kalyan(Executive Director & COO)in
BoardDr. Satyanarayana Chava(Chairman)
Co-investorsEight Roads Ventures
Metsera was a clinical-stage biotechnology company developing injectable and oral medicines for obesity and metabolic diseases, including next-generation GLP-1 and amylin-based therapies.
BiotechHealthtechMedical DevicesNew York, US
Clive A. Meanwell(Director)Christopher J. Visioli(Executive Officer)inBrian Hubbard(Executive Officer)inChristopher Whitten Bernard(Executive Officer, Director)Steven Marso(Executive Officer)Clive Meanwell(Founder)
Co-investorsAlpha Wave GlobalARCH Venture PartnersGV (Google Ventures)RA CapitalSoftBank Vision FundViking Global+5 more
nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications.
BiotechDeep TechMedical DevicesBoston, US
Luke Gilbert, PhD(Founder)Keith Joung, MD, PhD(Founder)David Liu, PhD(Founder)Angelo Lombardo, PhD(Founder)Luigi Naldini, MD, PhD(Founder)Jonathan Weissman, PhD
Co-investorsAtlas VentureNewpath Partners5AM VenturesARCH Venture PartnersDCVC (Data Collective)GV (Google Ventures)+11 more
Nocion Therapeutics develops small molecule charged sodium channel blockers (nocions) designed to silence overactive sensory nerves.
BiotechHealthtechMedical DevicesWatertown, US
MATTHEW FRANKEL(Executive Officer)inPETER COUROSSI(Executive Officer)RICHARD BATYCKY(President and Chief Executive Officer)JAMES ELLIS(Executive Officer)MICHAEL LIPP(Executive Officer)inCHRISTOPHER SILBER(Executive Officer)in
Co-investorsCanaan PartnersLumira VenturesMission BiocapitalMonograph Capital PartnersOUP (Osage University Partners)
Odaseva provides data management, backup, and protection tools built for large enterprises running Salesforce at scale.
Data & InfrastructureEnterprise SoftwareSaaSSan Francisco, US
Sovan Bin(CEO and Founder)in
Co-investorsCRESCENT COVE CAPITALEight Roads VenturesPartech VenturesSerenaEurazeoSerena Capital
OnCusp Therapeutics develops oncology therapeutics for cancer treatment, including antibody-drug conjugates and small molecule compounds in clinical and preclinical stages.
BiotechMedical DevicesNew York, US
Dr. Bing Yuan(Co-Founder, Chief Executive Officer)Dr. Eric Slosberg(Co-Founder, Chief Development Officer)Dr. Andy Fu(Co-Founder, Chief Business Officer)Bing Yuan, Ph.D., MBA(Co-Founder, Chief Executive Officer)Eric Slosberg, Ph.D.(Co-Founder, Chief Development Officer)Andy Fu, PharmD, MBA(Co-Founder, Chief Business Officer)
Co-investorsOrbiMedCatalio Capital Management, LPSofinnova VenturesDe Novo VenturesInsight PartnersNVIDIA
Quantum Circuits develops superconducting quantum computers using dual-rail qubits with built-in error detection, designed to accelerate the path to fault-tolerant quantum computing.
Advanced ManufacturingDeep TechHardwareQuantum ComputingMadison, US
Rob Schoelkopf(Sterling Professor, Founder)inLuigi Frunzio(Founder)Ray SmetsinMichel Devoret(Founder)Robert Schoelkopf(Founder)
Co-investorsARCH Venture PartnersCanaan PartnersConnecticut InnovationsFitz Gate VenturesIn-Q-TelOUP (Osage University Partners)+2 more
Rippl delivers evidence-based dementia care through a combination of technology and human support for people living with dementia and their families.
Digital HealthHealthtechSeattle, US
Kris Engskov(Co-founder & CEO)inRobert Nelsen(Co-Founder & Board Chair)Paul Engskov(Executive Officer, Director)
BoardHolly Maloney(Director)inIyah Romm(Director)Ryan Watts(Director)
Co-investors1843 CapitalARCH Venture PartnersCity LightEquitage Ventures, L.L.C.General CatalystGV (Google Ventures)+2 more
Shift Bioscience develops siRNA therapeutics for cell rejuvenation, using a target identification platform that has identified an anti-fibrotic candidate initially aimed at liver fibrosis.
AI & Machine LearningBiotechLongevityCambridge, GB
Daniel Ives(Founder & CEO)inBrendan Swain(Co-founder & CSO)in
Co-investorsIKJ CapitalKindred CapitalCambridge Innovation Capital
Space and Time provides blockchain indexing, secure offchain data, and zero-knowledge proofs for onchain financial applications.
Crypto & Web3Data & Infrastructure
Scott Dykstra(Founder)in
Co-investorsAlliance DAO (ex DeFi Alliance)Alumni VenturesArrington CapitalCircle VenturesDigital Currency GroupEterna Capital+12 more
Toku Eyes develops AI-driven solutions for eye health diagnostics and monitoring, bringing together medical expertise in endocrinology and ophthalmology with artificial intelligence capabilities.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Michael V. McConnell(Chief Health Officer and Interim CEO)inFrancesca Logan(Chief Commercial Officer)inYariv Levin(Chief Compliance, Ethics and Clinical Affairs Officer)in
Co-investorsArc AngelsIcehouse VenturesOutset VenturesBlockchain CapitalFunders Club Managementgmjp+8 more
Toku provides payroll infrastructure that lets companies pay teams in stablecoins, fiat, or tokens through a single API that integrates with existing systems like ADP, Gusto, and Workday.
Crypto & Web3Enterprise SoftwareFintechHR TechNew York, US
Kenneth O'Friel(Founder)inDominika Stobiecka(Cofounder)in
Co-investorsBlockchain CapitalFirestreak VenturesWinklevoss CapitalFunders Club ManagementgmjpGradient Ventures+7 more
Toku is a cloud communications provider offering customer experience solutions, including a hosted contact centre (CCaaS) offering, to businesses.
AI & Machine LearningCloud ComputingEnterprise SoftwareSaaSSingapore, SG
Thomas Laboulle(Founder)in
Co-investorsBetatron Venture GroupOSK Ventures InternationalBlockchain CapitalFunders Club ManagementgmjpGradient Ventures+7 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



























































































.png)




















